Fractional CO2 vs Fraxa 1550 for Acne Scars: What Actually Works on Indian Skin

The two technologies, briefly

Fractional CO2 at 10,600nm is ablative — it vaporises columns of tissue and stimulates aggressive dermal remodelling as the wounds heal. It is the most powerful non-surgical scar revision tool available and produces the most dramatic single-session improvement, at the cost of significant downtime and higher PIH risk.

Fractional erbium-doped glass at 1550nm (the wavelength popularised as "Fraxel" and now widely available under generic labels) is non-ablative — it heats columns of dermis without vaporising the epidermis. Results are more gradual, session counts higher, but downtime is minimal and PIH risk on darker skin is meaningfully lower.

Which scar types respond to which laser

Atrophic acne scars are usually classified into three morphologies, and the choice of laser depends heavily on which type dominates:

Ice pick scars — narrow, deep, sharply defined — respond poorly to any laser as a monotherapy. TCA CROSS or punch excision is the primary treatment; laser is used adjunctively to blend edges.

Rolling scars — broad, gently sloping — respond well to both fractional CO2 and 1550nm. CO2 delivers faster results (typically 40–60% improvement in 2 sessions); 1550nm reaches similar endpoints in 5–8 sessions.

Boxcar scars — sharply defined, U-shaped — are the best-case scenario for fractional lasers. Both technologies work; CO2 works faster.

Hypertrophic and keloidal acne scars require entirely different treatment (intralesional steroids, silicone, sometimes vascular lasers) and are not the focus here.

The PIH question on Indian skin

This is where the choice actually gets decided in Indian practice. Ablative fractional CO2 on Fitzpatrick IV skin has a well-documented post-inflammatory hyperpigmentation risk in the 25–40% range even with best-practice protocols (aggressive pre-treatment with hydroquinone, strict photoprotection, conservative fluences). On Fitzpatrick V, PIH risk climbs to 40–60%.

Fractional 1550nm carries roughly one-third the PIH risk at equivalent skin types — typically 10–15% on Fitzpatrick IV and 20–30% on Fitzpatrick V, with most cases mild and self-resolving within 8–12 weeks.

For patients on Fitzpatrick V–VI, 1550nm is often the safer starting point regardless of the theoretically faster CO2 outcome. PIH that persists for months erases the aesthetic gain of the scar improvement.

The 1550nm patient trades weeks of visible peeling for months of manageable sessions. The CO2 patient trades weeks of downtime for the risk of months of pigmentation.

Downtime: what patients actually experience

Fractional CO2 downtime after a full-face session:

• Days 1–3: significant erythema, oedema, mild oozing from ablated columns, patient largely housebound
• Days 4–7: peeling, "sandpaper" texture, patient can return to office work with makeup
• Weeks 2–3: pink base fades, final texture emerges by week 4

Fractional 1550nm downtime after a full-face session:

• Day 1: mild erythema, sunburn-like sensation for 4–6 hours
• Days 2–5: mild sandpaper texture and bronzing, most patients return to work day 2 or 3
• Week 2 onward: full recovery, next session possible at 4 weeks

For working professionals — the majority of Indian aesthetic patients — the 1550nm downtime profile is significantly easier to build into life. CO2 patients typically need at least one week of scheduled downtime.

Session counts and treatment timeline

A realistic treatment plan for moderate acne scarring (mixed rolling + boxcar, Fitzpatrick IV):

Fractional CO2 pathway: 2–3 sessions spaced 8–12 weeks apart. Total treatment timeline: 6–9 months. Total sessions: 2–3.

Fractional 1550nm pathway: 5–8 sessions spaced 4 weeks apart. Total treatment timeline: 5–8 months. Total sessions: 5–8.

Interestingly, the calendar time to completion is similar; the difference is session count and per-session downtime.

Combining with microneedling, subcision, TCA CROSS

Neither laser is a monotherapy for meaningful acne scarring. Standard combination protocols:

• Subcision for tethered rolling scars, 2–4 weeks before first laser session, releases fibrous bands so laser-induced neocollagenesis fills the newly-mobile depression
• TCA CROSS (60–90%) for ice pick scars, spot-applied every 6–8 weeks, run in parallel with fractional laser series
• PRP injection or topical application at time of laser session — modest additive benefit, meaningful patient enthusiasm
• Microneedling with radiofrequency as an alternative or complement to 1550nm on very dark skin where laser PIH risk is high

Machine investment: what a clinic pays

2026 landed-in-India pricing for fractional laser platforms:

• Fractional CO2 (mid-tier Chinese OEM, CE/FDA cleared): ₹6–12 lakh, single-wavelength platform, standard scanner handpieces
• Fractional CO2 (premium American — Lumenis UltraPulse, Sciton Halo hybrid): ₹25–55 lakh
• 1550nm non-ablative fractional (mid-tier OEM): ₹8–14 lakh
• 1550nm non-ablative fractional (premium — Solta Fraxel Dual): ₹30–45 lakh

For a clinic doing 15–25 scar patients per month, either technology pays back inside 12–18 months. For a clinic doing under 8 per month, the calculation is tighter — start with whichever also handles adjacent demand (CO2 doubles as a resurfacing platform for periorbital rejuvenation; 1550nm doubles as a general skin-quality treatment).

Choosing for your practice

The pragmatic recommendation for most Indian dermatology and aesthetic practices in 2026:

Start with 1550nm if your patient base is predominantly Fitzpatrick IV–VI and skews toward working professionals who can't take a week off. It's the safer clinical position, patients tolerate it better, and it doubles as a general skin-quality treatment that expands your service menu.

Start with fractional CO2 if you have surgical or dermatology depth, are comfortable managing post-laser complications, and your patient base skews toward Fitzpatrick III–IV with acceptance of downtime. The single-session results are dramatic and drive referral flywheel.

Ideal state: both platforms. Different scar phenotypes and skin phototypes respond best to different modalities, and clinics that offer both convert more patients from consultation to procedure.

Aveo offers both technologies. The Aveo CO2 is a fractional 10,600nm ablative platform with a scanning galvano handpiece, suitable for scar revision and periorbital rejuvenation. The Aveo Fraxa 1550 is a non-ablative fractional erbium-glass laser tuned for pigmentary safety on Indian skin. Both are CE marked, both come with installation, training, and India-based service. Get in touch on WhatsApp for a demo or a written quote.